Christopher D. Herzog

Author

Rush University Medical Center

Also Known As

C. Herzog, C.D Herzog, C.D. Herzog, Christopher D Herzog, Christopher D. Herzog, Christopher Herzog

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center Rutgers, The State University of New Jersey Washington University in St. Louis Cereneo University of California San Diego

About

Christopher D. Herzog is an author at Rush University Medical Center specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	982
2	Social Sciences	4	4	224
3	Health Sciences	1	1	152
4	Biomolecular Engineering	1	1	29
5	Cell Biology	1	1	153

Christopher D. Herzog

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Gene delivery of neurturin to putamen and substantia nigra in <scp>P</scp>arkinson disease: A double‐blind, randomized, controlled trial C. Warren Olanow, Raymond T. Bartus, Tiffany Baumann, Annals of Neurology	2015	277
Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys Jeffrey H. Kordower, Christopher D. Herzog, Biplob Dass, Annals of Neurology	2006	253
A phase1 study of stereotactic gene delivery of AAV2‐NGF for Alzheimer's disease Michael S. Rafii, Tiffany Baumann, Roy A.E. Bakay, Alzheimer s & Dementia	2014	220
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients Raymond T. Bartus, Tiffany Baumann, João Siffert, Neurology	2013	205
Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains Raymond T. Bartus, Christopher D. Herzog, Yaping Chu, Movement Disorders	2010	167
Striatal Delivery of Neurturin by CERE-120, an AAV2 Vector for the Treatment of Dopaminergic Neuron Degeneration in Parkinson's Disease Mehdi Gasmi, Christopher D. Herzog, Eugene P. Brandon, Molecular Therapy Aav2 VectorDopaminergic NeuronsMedicineStriatal DeliveryNeuropharmacology	2006	153
Injection of IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits Thomas J. Walsh, Christopher D. Herzog, Chetan C. Gandhi, Brain Research Basal GangliaSynaptic TransmissionNeurotransmitterNeurotransmissionMemory Deficits	1996	152
AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease Mehdi Gasmi, Eugene P. Brandon, Christopher D. Herzog, Neurobiology of Disease Neurodegenerative DiseasesMedicineNeuropharmacologyNeuroprotectionNeurology	2007	141
Striatal delivery of CERE‐120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys Christopher D. Herzog, Biplob Dass, James E. Holden, Movement Disorders Aged MonkeysSynaptic TransmissionNeurotransmissionSynaptic SignalingSocial Sciences	2007	136
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s disease Jodi L. McBride, Shilpa Ramaswamy, Mehdi Gasmi, Proceedings of the National Academy of Sciences	2006	102

Page 1